Wick Husten-Löser Pregnancy

Did you have any side effects with this medicine?

 No   Yes 

• Pregnancy of Wick Husten-Löser in details
• Wick Husten-Löser breastfeeding
• Wick Husten-Löser reviews

Pregnancy of Wick Husten-Löser in details

The Collaborative Perinatal Project reported 197 first-trimester exposures to Wick Husten-Löser. Fourteen malformations were reported for a relative risk not significantly different from 1.0. In a review of 229,101 deliveries to Michigan Medicaid patients, 141 first-trimester exposures to Wick Husten-Löser and 349 exposures anytime during pregnancy were recorded. A total of 9 birth defects were reported with first trimester exposure (6 expected) and included 2 cardiovascular defects. These data do not support an association between Wick Husten-Löser and birth defects. (written communication, Franz Rosa, MD, Food and Drug Administration, 1994)

Wick Husten-Löser has been assigned to pregnancy category C. by the FDA. There are no controlled data in human pregnancy. Wick Husten-Löser is only recommend for use during pregnancy when benefit outweighs risk.

See references

Wick Husten-Löser breastfeeding

There are no data on the excretion of Wick Husten-Löser into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

1. "Product Information. Humabid (Wick Husten-Löser)." Medeva Pharmaceuticals, Rochester, NY.
2. Heinonen O, Slone D, Shapiro S; Kaufman DW ed. "Birth Defects and Drugs in Pregnancy." Littleton, MA: Publishing Sciences Group, Inc. (1977): 297

References for breastfeeding information

1. Covington TR, Lawson LC, Young LL, eds. "Handbook of Nonprescription Drugs. 10th ed." Washington, DC: American Pharmaceutical Association (1993):

References

1. DailyMed. "GUAIFENESIN; HYDROCODONE BITARTRATE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
2. PubMed Health. "Mucinex: This section provide the link out information of drugs collectetd in PubMed Health. ". http://www.ncbi.nlm.nih.gov/pubmedhe... (accessed September 17, 2018).
3. Human Metabolome Database (HMDB). "Guaifenesin: The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.". http://www.hmdb.ca/metabolites/HMDB0... (accessed September 17, 2018).

Reviews

Consumer reviews

Information checked by Dr. Sachin Kumar, MD Pharmacology